HCPLive Network

Care Based on Intracranial Pressure Not Superior in Traumatic Brain Injury

 
WEDNESDAY, Dec. 12 (HealthDay News) -- For patients with severe traumatic brain injury (TBI) treated in the intensive care unit, treatment based on maintaining monitored intracranial pressure is not superior to care based on imaging and clinical examination, according to a study published online Dec. 12 in the New England Journal of Medicine.

Randall M. Chesnut, M.D., from the University of Washington in Seattle, and colleagues conducted a multicenter trial involving 324 patients aged 13 years or older with severe TBI. The participants were randomly allocated to receive guidelines-based management, in which a protocol for monitoring intraparenchymal intracranial pressure was used, or a treatment protocol based on imaging and clinical examination.

The researchers observed no significant difference between the groups in the primary outcome, a composite measure based on 21 assessments of functional and cognitive status, and six-month mortality was also not significantly different between the groups (P = 0.60). There was no significant difference in the median length of stay in the intensive care unit between the groups, although the imaging-clinical examination group had a higher number of days of brain-specific treatments (4.8 versus 3.4; P = 0.002). There was a similar distribution of serious adverse events between the groups.

"Our data suggest that a reassessment of the role of manipulating monitored intracranial pressure as part of multimodality monitoring and targeted treatment of severe traumatic brain injury is in order," the authors write.

The study was funded in part by Integra Life Sciences; all of the study authors disclosed financial ties to Integra Life Sciences as well as to two personal injury law firms.
 

Abstract
Full Text
Editorial

 
Copyright © 2012 HealthDay. All rights reserved.
 
 

Further Reading
Patients diagnosed with type 1 diabetes have long known the benefits of ease and convenience that comes with using an insulin pump instead of relying on multiple daily insulin injections to control their condition. A recent study has shown that using a pump is also associated with positive effects on long-term cardiovascular risk and mortality.
According to an analysis of various scenarios, racial and ethnic factors may contribute to care and behavior in post-spinal cord and brain injury care.
Bodily pain and headache are highly prevalent in pituitary disease, making pain screening and therapy an important part of the work-up for these patients.
Researchers at the Children’s Hospital of Philadelphia recently released the results of a study that identified a protein that could play a key role in a variety of diseases.
Artificial sweeteners can potentially make blood glucose levels rise despite containing no calories, researchers report online Sept. 17 in Nature.
Stendra (avanafil) is now the only FDA-approved erectile dysfunction (ED) medication indicated to be taken as early as approximately 15 minutes before sexual activity.
Scientists have uncovered a key factor to explain why antibiotic-resistant bacteria can thrive in a hospital setting. These findings have published in the Sept. 17 issue of Science Translational Medicine.
More Reading